Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,484.80
(
-0.99%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
105.10
(
0.00%
)
Bitcoin
69,157.16
(
0.39%
)
News Focus
News Focus
Post# of 257268
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

urche

Send PM Follow Ignore
Followers 7
Posts 996
Boards Moderated 0
Alias Born 10/06/2004

urche

Re: DewDiligence post# 26835

Thursday, 04/06/2006 8:02:25 AM

Thursday, April 06, 2006 8:02:25 AM

Post# of 257268
CYTO

The interesting thing to me about that PR from Cyto is no mention of PSMA Development company, the 50/50 JV with Progenics that I thought held great promise for developing PSMA based drugs. But ever since the partnership was announced, virtually no public progress has been made. The PSMA based product described in this PR is a logical outgrowth of Cyto's current pipeline. I think it sounds like a promising approach.

urche
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today